AURO-DAPAGLIFLOZIN

ਉਤਪਾਦ ਝਲਕ

About AURO-DAPAGLIFLOZIN

AURO-DAPAGLIFLOZIN is a prescription medication containing the active ingredient Dapagliflozin, used to treat type 2 diabetes. It belongs to a class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors, which work by reducing the amount of glucose reabsorbed by the kidneys and promoting its excretion in the urine.

Key Benefits & Uses

• Improves glycemic control in adults with type 2 diabetes, reducing HbA1c levels and fasting plasma glucose levels.
• Helps to reduce the risk of major adverse cardiovascular events, such as heart attack, stroke, or death, in adults with established cardiovascular disease or multiple cardiovascular risk factors.
• May also be used to reduce the risk of hospitalization for heart failure in adults with heart failure with reduced ejection fraction.

Active Ingredient & Action

Dapagliflozin, the active ingredient in AURO-DAPAGLIFLOZIN, works by inhibiting the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose from the urine back into the bloodstream. By blocking this protein, Dapagliflozin increases the excretion of glucose in the urine, reducing blood glucose levels and improving glycemic control.

Important Notes

Before taking AURO-DAPAGLIFLOZIN, inform your doctor if you have any kidney problems, as Dapagliflozin may increase the risk of kidney damage. Also, inform your doctor if you are pregnant or breastfeeding, as the safety of Dapagliflozin in these situations is not well established. It is essential to follow a healthy diet and exercise regularly while taking AURO-DAPAGLIFLOZIN to achieve optimal results.